Genprex, Inc. (GNPX) SEC Filing 8-K Material Event for the period ending Wednesday, April 29, 2020

Genprex, Inc.

CIK: 1595248 Ticker: GNPX

View differences made from one to another to evaluate Genprex, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Genprex, Inc..


Assess how Genprex, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Genprex, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Genprex, Inc. provided additional information to their SEC Filing as exhibits

Ticker: GNPX
CIK: 1595248
Form Type: 8-K Corporate News
Accession Number: 0001437749-20-009269
Submitted to the SEC: Mon May 04 2020 4:30:40 PM EST
Accepted by the SEC: Mon May 04 2020
Period: Wednesday, April 29, 2020
Industry: Pharmaceutical Preparations
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: